Healthy Aging & Longevity
Age-Related Decline & Frailty
Loss of energy, strength and resilience with age.
About this condition
Frailty and age-related decline are linked to chronic low-grade inflammation. Longevity protocols aim to support healthy function.
How we approach it
We start with biomarker and genomic testing to understand your baseline, then build a protocol measured against those same markers at follow-up.
Therapies we may consider
How to prepare
- •Gather your records: diagnosis letters, recent lab results, imaging reports (MRI, X-ray, CT) and a medication list.
- •Keep taking prescribed medication — we never ask you to stop treatment from your own doctor.
- •Ask your specialist whether they are willing to share notes with our physicians; coordinated care is safer.
- •Write down your main goals and current symptoms (for example, pain on a 0–10 scale or walking distance) so we can measure change honestly.
- •Plan your trip: most programs need 2–5 days in Los Cabos, and you should avoid long flights for 24 hours after joint procedures if possible.
Possible side effects
Depends on the therapy your physician recommends. Most are mild and short-lived.
Mesenchymal Stem Cells
- · Mild fatigue, low-grade fever or chills in the first 24–48 hours after infusion
- · Headache or mild nausea
- · Soreness, swelling or stiffness at the injection site for a few days (joint injections)
- · Bruising at the IV site
Peptide & NAD+ Protocols
- · During NAD+ infusion: chest tightness, flushing, nausea, cramping or headache — these usually settle quickly when the drip is slowed
- · Injection-site redness for peptides
- · Mild fatigue
Selected published research
Allogeneic MSCs ameliorate aging frailty: a phase II randomized, placebo-controlled trial
Tompkins BA et al., J Gerontol A, 2017
Improvements in walking distance and inflammatory markers compared with placebo.
HBOT increases telomere length and decreases immunosenescence
Hachmo Y et al., Aging, 2020
Markers of cellular ageing improved in older adults after a 60-session HBOT course.
Nicotinamide riboside elevates NAD+ in middle-aged and older adults
Martens CR et al., Nat Commun, 2018
NAD+ levels rose and supplementation was well tolerated.
Links open PubMed or the original source. Study results do not guarantee individual outcomes.
What the evidence says
Research is early-stage. Protocols are offered on an investigational basis after thorough physician review.
We do not promise cures or specific outcomes. Read our safety & eligibility page.
Wondering if you're a candidate?
A physician will review your records and give you an honest answer.
Book a Consultation